Biora Therapeutics, Inc. BIORQ
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | -108.70M | -122.42M |
| Total Depreciation and Amortization | -- | -- | -- | 438.00K | 596.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | 1.13M | 1.49M |
| Total Other Non-Cash Items | -- | -- | -- | 62.97M | 62.52M |
| Change in Net Operating Assets | -- | -- | -- | 9.42M | 12.04M |
| Cash from Operations | -- | -- | -- | -34.75M | -45.77M |
| Capital Expenditure | -- | -- | -- | -37.00K | -109.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 11.00K | 11.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -26.00K | -98.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | -- | -- | -- | 13.06M | 15.63M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 3.80M | 5.75M |
| Cash from Financing | -- | -- | -- | 16.86M | 21.38M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | -17.92M | -24.49M |